Aug 22, 2023, 18:16
Aaron Goodman: The way we treat multiple myeloma will bankrupt the system and further enrich pharma.
According to Aaron Goodman on Twitter/X:
“The way we treat multiple myeloma will bankrupt the system and further enrich pharma. Soon we will be moving CART and BiTES to earlier lines (even asymptomatic smoldering) based off a surrogate endpoints. Our patients and society deserve better.”
Source: Aaron Goodman/Twitter
Aaron Goodman, MD is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 12:55
Dec 23, 2024, 12:47
Dec 23, 2024, 12:47
Dec 23, 2024, 12:23
Dec 23, 2024, 12:11
Dec 23, 2024, 12:00